上海三维生物技术有限公司

 
展示
 
 
 
 

Corporate briefing

Shanghai Sunway Biotech Co., Ltd is located in Jinqiao Export Processing Zone of Pudong area. Our company occupies 14,342 square meters with construction area of 4,500 square meters.

Products

SunGran(rhG-CSF), developed by Sunway Biotech and Chinese military academy of science, was one of the results of “State 863 Project”. Got new drug certification (national second-class drug) in May 1998 and a formal production approval in October 1998. The export of SunGran in 2005 also made a historic breakthrough. Thanks to the company’s strategy, sales of SunGran are well in China, Indian, Pakistan and other countries and increase greatly for these years.
 
Oncorine, the first oncolytic adenoviruses medication in the world, has outstanding efficacy and little side effect in curing those patients who have applied chemotherapy and radiotherapy but failed or those who plan to use chemotherapy and radiotherapy concomitant with it. Oncorine was listed as one of the projects under the China national "863 Program" and the Technology Innovation Fund in 2000, Shanghai High-tech Transformation Project in 2004. And Oncorine got certification of new drugs in October 2005, formal approval to produce in April 2006 and marketed in the year later. H103 (oncolytic recombinant adenovirus injection) has completed Phase I clinical trials and H102 completed pre-clinical studies.

 
 
 
 
 

沟通合作

  • 总部地址:上海市浦东新区金桥出口加工区桂桥路1150号C座
  • 邮编:201206
  • 传真:021-58999488
  • 电话:021-50310270
  • e-mail:sunwaybio@sunwaybio.com.cn
 
 
 
 
 

Research and development

Offering new hope for cancer patients, Shanghai Sunway Biotech has developed products (SunGran, Oncorine and its upgrading product version H102 and H103) that can cure their disease and improve their life quality. Now, H102 has gone through its pre-clinical phase, and H103 has finished phaseⅠclinical study.

 

Intellectual Property Rights

During the study and development of these products, our company has completed applying for 12 patents in different countries, such as in China, in America and in Japan. Among all of these, 9 applications have been authorized till now.

 

Services

The services we offer consist of protein and virus production which can meet the need for clinical researches. These services include cGMP cell and virus bank manufacturing, process development and pilot studies, lot manufacturing. Our technologies consist of cell culture technologies, downstream processing technologies and fermentation technologies. With high standard quality control system, we are competent to satisfy your needs.

 
 
 
 
 
 
总部地址:上海市浦东新区金桥出口加工区桂桥路1150号C座    邮编:201206    传真:021-58999488    电话:021-50310270    e-mail:sunwaybio@sunwaybio.com.cn